Accommodating Multiple ATMP Modalities in the Same Facility

Over the last decade, CGT Catapult has worked with industry in the development, production and adoption of ATMPs.  CGT Catapult is an independent innovation and technology organization committed to the advancement of cell and gene therapies, with a vision for a thriving industry delivering life-changing advanced therapies to the world.  PM Group designed the Catapult facility and will describe a process they have developed to accommodate multiple modalities within the same facility that is starting to be used more widely within the industry.  CGT Catapult will then explain how they have been able to remain compliant having received multiple GXP inspections for a range of different ATMP modalities.